TYPHIM Vi

Medicinal product

(Invented) name

TYPHIM Vi

Active substance (s)

Salmonella typhi (Ty2 padermės) polisacharidas

Strength

25 µg/dozėje

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į raumenis, leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J07AP03, Typhoid, purified polysaccharide antigen

Marketing authorisation holder

UAB Adeofarma, Lietuva

Date of authorisation

2020-06-29

Date of renewal

Documents

1325_TYPHIM Vi_inj_tirp_PZPL_2020-06-29.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Dozėje (0,5 ml) yra	0.5 ml
Salmonella typhi (Ty2 padermės) polisacharidas	25 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
104616	90718	1090718	užpildytas švirkštas	0,5 ml N1	ASPĮ	Receptinis	LT/L/20/1325/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2020-06-29	Registruotas